Bone-marrow transplantation in acute leukaemia

Area of Science:

• Hematology
• Oncology
• Transplant Immunology

Background:

• Leukemia is a significant cause of cancer mortality.
• Resistant leukemia presents a therapeutic challenge with poor prognoses.
• Conventional chemotherapy often fails in advanced or refractory leukemia cases.

Purpose of the Study:

• To compare the survival outcomes of patients with resistant leukemia treated with bone marrow transplantation versus conventional chemotherapy.
• To evaluate the efficacy of bone marrow transplantation in achieving long-term remission in leukemia.

Main Methods:

• A comparative study involving 33 patients undergoing marrow transplantation and 37 matched patients receiving chemotherapy.
• Assessment of leukemia remission status and overall survival rates in both treatment groups.
• Long-term follow-up to determine sustained remission and survival.

Main Results:

• All patients receiving bone marrow transplants achieved leukemia remission, with durations ranging from 36 days to over 2.5 years.
• Only 6 patients in the chemotherapy group achieved hematological remission.
• Five patients (15%) in the transplant group survived long-term (1-2.5 years) in remission, while no chemotherapy patients survived beyond 13 months.

Conclusions:

• Bone marrow transplantation provides a small but significant opportunity for long-term survival in patients with acute leukemia resistant to standard therapies.
• Marrow transplantation demonstrates superior efficacy in achieving durable remission compared to chemotherapy for resistant leukemia.
• Further research into optimizing bone marrow transplantation protocols for leukemia is warranted.